CMPX Earnings

Quarterly EPS
$-0.08
Q3 2024
$-0.11
Q4 2024
$-0.12
Q1 2025
$-0.14
Q2 2025
$-0.08
Q3 2025
$-0.08
Q4 2025
$-0.10
Q1 2026
$-0.13
Q2 2026
Latest RevenueN/A
Latest Net Income-25154000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.130-25154000—+7.1%
Q1 2026-$0.100-18317000—+16.7%
Q4 2025-$0.080-15716000—+27.3%
Q3 2025-$0.080-14259000—+0.0%
Q2 2025-$0.140-19881000-100.0%-40.0%
Q1 2025-$0.120-16633000—-50.0%
Q4 2024-$0.110-15033000—+0.0%
Q3 2024-$0.080-10481000—+0.0%
Q2 2024-$0.10850.0K-13076000——
Q1 2024-$0.080-10787000——
Q4 2023-$0.110-13415000——
Q3 2023-$0.080-9964000——
Compass Therapeutics (CMPX) — Earnings